Brett Mueller, DO
Ophthalmology · Fort Worth, TXNPI 1053730077
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $109,711 of the $160,279 with a category attached, or 68.4%. Alcon accounts for 69.6% of it on its own, with 27 other manufacturers making up the rest. Among ophthalmology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 439 payments — averaging $365.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$111K
- Bausch & Lomb Americas Inc.$11K
- Alcon Research LLC$10K
- Rxsight Inc$9K
- AbbVie$4K
- Johnson & Johnson Surgical Vision, Inc.$3K
- plus $13K from 22 others
Across 8 payments — averaging $22,899 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alcon Research LLC$167K
- Rxsight Inc$16K
What the payments were for
- Consulting fees$109,71168%
- Speaking & faculty fees$14,6639%
- Travel & lodging$19,85312%
- Food & beverage$15,94010%
- Education$1130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 141 | $111,486 |
| Bausch & Lomb Americas Inc. | 18 | $10,509 |
| Alcon Research LLC | 8 | $10,069 |
| Rxsight Inc | 59 | $9,246 |
| AbbVie(2 entities) | 26 | $3,565 |
| Johnson & Johnson Surgical Vision, Inc. | 54 | $2,865 |
| Lumibird Medical Inc. | 3 | $2,750 |
| Tarsus Pharmaceuticals, Inc. | 6 | $2,204 |
| Omeros Corporation | 6 | $1,643 |
| Biotissue Holdings Inc. | 28 | $1,589 |
| Glaukos Corporation | 15 | $1,459 |
| Beaver-visitec International, Inc. | 16 | $623 |
| Carl Zeiss Meditec USA, Inc. | 9 | $548 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 10 | $276 |
| Rayner Intraocular Lenses Limited | 7 | $260 |
| Lensar, Inc. | 2 | $233 |
| Sun Pharmaceutical Industries Inc. | 6 | $171 |
| Carl Zeiss Meditec, Inc. | 1 | $149 |
| Sight Sciences, Inc. | 5 | $131 |
| Novartis | 7 | $128 |
| Staar Surgical Company | 1 | $125 |
| Dompe US, Inc. | 3 | $64 |
| Oyster Point Pharma, Inc. | 2 | $51 |
| Ocular Therapeutix, Inc. | 2 | $43 |
| Lombart Brothers, Inc. | 1 | $39 |
| Tearlab Corp | 1 | $22 |
| Shire North American Group Inc | 1 | $19 |
| Quidel Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wavelight Refractive Suite$57,336
- Wavelight$28,394
- WaveLight EX500 Excimer Laser$28,394
- enVista MX60 IOL$8,316
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$6,801
- AcrySof IQ PanOptix UV IOL$5,500
- Centurion$4,650
- Clareon$4,621
- AcrySof IQ VIVITY$3,500
- AcrySof IQ VIVITY IOL$2,100
- AcrySof IQ PanOptix$2,100
- VUITY$1,750
- ENVISTA ENVY IOL$1,700
- OMIDRIA$1,564
- Fidelis$1,500
- RXSIGHT CONTACT LENS$1,057
- RXSIGHT INJECTOR CARTRIDGE$1,057
- RXSIGHT INJECTOR HANDPIECE$1,057
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$1,057
- Prokera$990
How this compares
$160,279 in reported general payments places this provider in the 95th percentile of 1,355 ophthalmology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bromfenac Sodium | 11 | $1,380 |
| Prednisolone Acetate | 29 | $883 |
| MoxifloxacinMoxifloxacin Hcl | 18 | $411 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Fort Worth
- Taylor StrangeFort Worth$179K
- Brian FlowersFort Worth$156K
- Michael SingerSan Antonio$1.8M
- Oluwatosin SmithDallas$1.5M
- Charles WykoffBellaire$1.5M
- John MichelettiHouston$916K
- Davinder GroverDallas$705K
- Christina WengHouston$676K
- Peter ChangHouston$656K
- Zaina Al-MohtasebHouston$636K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.